5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.32▼ | 1.32▼ | 1.32▼ | 1.36▼ | 1.64▼ |
MA10 | 1.34▼ | 1.34▼ | 1.34▼ | 1.51▼ | 2.36▼ |
MA20 | 1.37▼ | 1.38▼ | 1.37▼ | 1.64▼ | 4.87▼ |
MA50 | 1.44▼ | 1.51▼ | 1.57▼ | 2.70▼ | 17.13▼ |
MA100 | 1.61▼ | 1.64▼ | 1.79▼ | 5.53▼ | 28.72▼ |
MA200 | 1.76▼ | 2.05▼ | 2.44▼ | 14.05▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.000▲ | 0.003▲ | 0.043▲ | 0.399▲ |
RSI | 40.738▼ | 40.745▼ | 39.484▼ | 32.271▼ | 19.769▼ |
STOCH | 24.916 | 27.502 | 14.895▼ | 7.962▼ | 2.965▼ |
WILL %R | -72.727 | -85.000▼ | -90.000▼ | -94.478▼ | -99.020▼ |
CCI | -73.387 | -81.852 | -68.194 | -123.536▼ | -101.007▼ |
Thursday, May 16, 2024 04:00 PM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
|
Wednesday, May 15, 2024 09:53 PM
Longeveron (NASDAQ: LGVN) , a clinical-stage, regenerative-medicine biotechnology company developing cellular therapies for life-threatening and chr ...
|
Wednesday, May 15, 2024 05:00 PM
Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 1.32 | 1.32 | 1.28 | 1.31 | 293,387 |
15/05/24 | 1.42 | 1.49 | 1.29 | 1.34 | 498,334 |
14/05/24 | 1.28 | 1.58 | 1.28 | 1.39 | 714,507 |
13/05/24 | 1.35 | 1.35 | 1.265 | 1.29 | 487,264 |
10/05/24 | 1.59 | 1.59 | 1.43 | 1.455 | 300,439 |
09/05/24 | 1.67 | 1.6793 | 1.515 | 1.54 | 345,641 |
08/05/24 | 1.71 | 1.71 | 1.60 | 1.66 | 231,372 |
07/05/24 | 1.67 | 1.73 | 1.65 | 1.68 | 355,785 |
06/05/24 | 1.77 | 1.7708 | 1.66 | 1.68 | 289,029 |
03/05/24 | 1.81 | 1.88 | 1.73 | 1.75 | 395,492 |
|
|
||||
|
|
||||
|
|